✦ LIBER ✦

Dicer and Drosha expression and response to Bevacizumab-based therapy in advanced colorectal cancer patients

✍ Scribed by Vincenzi, Bruno; Zoccoli, Alice; Schiavon, Gaia; Iuliani, Michele; Pantano, Francesco; Dell’Aquila, Emanuela; Ratta, Raffaele; Muda, Andrea Onetti; Perrone, Giuseppe; Brunelli, Chiara; Correale, Pierpaolo; Riva, Elisabetta; Russo, Antonio; Loupakis, Fotios; Falcone, Alfredo; Santini, Daniele; Tonini, Giuseppe

Book ID: 122940296
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 705 KB
Volume: 49
Category: Article
ISSN: 0959-8049
DOI: 10.1016/j.ejca.2012.11.014

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

p53 and PCNA expression in advanced colo

p53 and PCNA expression in advanced colorectal cancer: Response to chemotherapy and long-term prognosis

✍ Angelo Paradiso; Mario Rabinovich; Carlos Vallejo; Mario Machiavelli; Alberto Ro 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 French ⚖ 660 KB

In a series of 71 patients with advanced colorectal cancer treated with biochemically modulated 5-fluorouracil(5-FU) and methotrexate (MTX), we investigated the relationship between the proliferating-cell nuclear antigen (PCNA) (PC 10) and p53 (Pab I80 I) primary-tumor immunohistochemical expression

XELOX and bevacizumab followed by single

XELOX and bevacizumab followed by single-agent bevacizumab as maintenance therapy as first-line treatment in elderly patients with advanced colorectal cancer: the boxe study

✍ Rosati, Gerardo; Avallone, Antonio; Aprile, Giuseppe; Butera, Alfredo; Reggiardo 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 269 KB

CEA and CA19.9 as Early Predictors of Pr

CEA and CA19.9 as Early Predictors of Progression in Advanced/Metastatic Colorectal Cancer Patients Receiving Oxaliplatin-Based Chemotherapy and Bevacizumab

✍ Petrioli, Roberto; Licchetta, Antonella; Roviello, Giandomenico; Pascucci, Aless 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 273 KB

Peripheral blood guanylyl cyclase c (GCC

Peripheral blood guanylyl cyclase c (GCC) expressions are associated with prognostic parameters and response to therapy in colorectal cancer patients

✍ Celalettin Camci; Akif Şahin; Alper Sevinc; Mehmet E. Kalender; Serdar Öztuzcu; 📂 Article 📅 2011 🏛 S. Karger AG 🌐 English ⚖ 122 KB

p53 protein overexpression and response

p53 protein overexpression and response to biomodulated 5-fluorouracil chemotherapy in patients with advanced colorectal cancer

✍ Martin C. Brett; Mark Pickard; Bryan Green; Amanda Howel-Evans; David Smith; Ann 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 372 KB

Gene expression signature and response t

Gene expression signature and response to the use of leucovorin, fluorouracil and oxaliplatin in colorectal cancer patients

✍ Toshiaki Watanabe; Takashi Kobunai; Yoko Yamamoto; Keiji Matsuda; Soichiro Ishih 📂 Article 📅 2011 🏛 Springer Milan 🌐 Spanish ⚖ 473 KB